Edward B. Garon - Publications, H-index & Citations

Edward B. Garon

UCLA

76H指数

732论文数

5.5W被引数

收录论文 158

发表时间

Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis 作者更正: 血液中肿瘤突变的灵敏检测及其在免疫治疗预后中的应用

Nature Communications

IF15.7

2026-02-05

OAAI

Shuo Li; Zorawar S. Noor; Weihua Zeng; Mary L. Stackpole; Xiaohui Ni; Yonggang Zhou; Zuyang Yuan; Wing Hung Wong; Vatche G. Agopian; Steven M. Dubinett; Frank Alber; Wenyuan Li; Edward B. Garon; Xianghong Jasmine Zhou

Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer 立体定向体部放射治疗在Ⅰ期非小细胞肺癌中的应用趋势

CHEST

IF8.6

2025-11-12

PREAI

Sara Sakowitz; Haley I. Tupper; Lawrence N. Benjamin; Scott Oh; Tao He; Reza Ronaghi; Colleen L. Channick; Brian J. Rosenberg; Ramin Salehi-rad; Malcolm I. Smith; Joanne M. Bando; Timothy J. Young; Igor Barjaktarvic; Maria A. Velez Velez; Arjan Gower; Amy L. Cummings; Jonathan Goldman; Aaron E. Lisberg; Edward B. Garon; Jane Yanagawa

First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study 一线Sacituzumab Govitecan联合Pembrolizumab治疗转移性NSCLC：EVOKE-02研究PD-L1 TPS <50%和≥50%队列

Journal of Thoracic Oncology

IF20.8

2025-10-30

PREAI

Martin Reck; Jyoti D. Patel; Jhanelle E. Gray; Noemí Reguart; Manuel Cobo; José Fuentes Pradera; Enriqueta Felip; Federico Cappuzzo; Edward B. Garon; Joel W. Neal; Sabeen Mekan; Farnoush Safavi; Nelumka Fernando; Marianna Zavodovskaya; Juliane M. Jürgensmeier; Michael Chisamore; Byoung Chul Cho

Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework 与申诉和投资回报相关的临床试验特征：一项综述和框架

ONCOLOGIST

IF4.2

2025-10-01

OAAI

Fernandez Turizo, Maria J.; Velez, Maria A.; Glenn, Beth; Cummings, Amy L.; Segarra-Vazquez, Barbara; Gorbatov, Sarah; Park, Seung J.; Shen, Collin; Lind-Lebuffe, Jackson P.; Unger, Joseph M.; Garon, Edward B.

Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer 对局部晚期非小细胞肺癌进行新辅助化免疫疗法后手术治疗的无限热情

Lung Cancer

IF4.4

2025-06-20

PREAI

Drew Moghanaki; Emily A. Cameron; Edward B. Garon

Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients 简报：无吸烟史小细胞肺癌的基因组景观

Clinical Lung Cancer

IF3.3

2025-03-31

OAAI

Michael S. Oh; Edward B. Garon; Aaron E. Lisberg; Amy L. Cummings; Alex Barrett; Arya Ashok; Elizabeth Mauer; Binyam Yilma; Jonathan W. Goldman

Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2024-11-19

PREAI

Oh, Michael S.; Dumitras, Camelia; Salehi-Rad, Ramin; Tran, Linh M.; Krysan, Kostyantyn; Lim, Raymond J.; Jing, Zhe; Tappuni, Shahed; Lisberg, Aaron; Garon, Edward B.; Dubinett, Steven M.; Liu, Bin

RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC RELAY研究：厄洛替尼联合ramucirumab或安慰剂在未治疗、EGFR突变型转移性NSCLC中的最终总生存期

JOURNAL OF THORACIC ONCOLOGY

IF20.8

2024-11-01

PREAI

Nakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin

RELAY: final overall survival with erlotinib plus ramucirumab or placebo in untreated, EGFR-mutated metastatic NSCLC (mNSCLC)

ANNALS OF ONCOLOGY

IF65.4

2024-10-01

PREAI

Nakagawa, K.; Garon, E. B.; Nishio, M.; Seto, T.; Nishio, K.; Kasahara, K.; Nishino, K.; Satouchi, M.; Yoh, K.; Hayashi, H.; Enatsu, S.; Frimodt-Moller, B.; Matsui, T.; Varughese, S. C.; Visseren-Grul, C.; Reck, M.

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

NATURE MEDICINE

IF50

2024-09-30

PREAI

Alban, Tyler J.; Riaz, Nadeem; Parthasarathy, Prerana; Makarov, Vladimir; Kendall, Sviatoslav; Yoo, Seong-Keun; Shah, Rachna; Weinhold, Nils; Srivastava, Raghvendra; Ma, Xiaoxiao; Krishna, Chirag; Mok, Juk Yee; van Esch, Wim J. E.; Garon, Edward; Akerley, Wallace; Creelan, Benjamin; Aanur, Nivedita; Chowell, Diego; Geese, William J.; Rizvi, Naiyer A.; Chan, Timothy A.

TRIDENT: Machine learning (ML) multimodal signatures to identify patients that would benefit most from tremelimumab (T) addition to durvalumab (D) plus chemotherapy (CT) with data from the POSEIDON trial TRIDENT：利用机器学习（ML）的多模态特征识别从曲美木单抗（T）联合度伐利尤单抗（D）和化疗（CT）中获益最多的患者，数据来源于POSEIDON试验

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Skoulidis, F.; Jabbour, S.; Garon, E. B.; Iyengar, P.; Scagliotti, G.; Ferrer, L.; Etchepare, G.; Gallinato, O.; Faure, J.; Bernard, P.; Colin, T.; Menu, P.; Lin, Y.; Cai, L.; Faria, J.; Remorino, A.; Luciani-Silverman, L.; Miller, K. P.; Dellamonica, D.; Zhang, Y.

Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities

NPJ PRECISION ONCOLOGY

IF8

2024-08-05

OAAI

Lozac'hmeur, Ariane; Danek, Tyler; Yang, Qidi; Rosasco, Mario G.; Welch, John S.; Go, William Y.; Ng, Eric W.; Mardiros, Armen; Maloney, David G.; Garon, Edward B.; Kirtane, Kedar; Simeone, Diane M.; Molina, Julian R.; Salahudeen, Ameen A.; Stein, Michelle M.; Hecht, J. Randolph

Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer (vol 13, 5566, 2022)

NATURE COMMUNICATIONS

IF15.7

2024-05-01

OAAI

Stackpole, Mary L.; Zeng, Weihua; Li, Shuo; Liu, Chun-Chi; Zhou, Yonggang; He, Shanshan; Yeh, Angela; Wang, Ziye; Sun, Fengzhu; Li, Qingjiao; Yuan, Zuyang; Yildirim, Asli; Chen, Pin-Jung; Winograd, Paul; Tran, Benjamin; Lee, Yi-Te; Li, Paul Shize; Noor, Zorawar; Yokomizo, Megumi; Ahuja, Preeti; Zhu, Yazhen; Tseng, Hsian-Rong; Tomlinson, James S.; Garon, Edward; French, Samuel; Magyar, Clara E.; Dry, Sarah; Lajonchere, Clara; Geschwind, Daniel; Choi, Gina; Saab, Sammy; Alber, Frank; Wong, Wing Hung; Dubinett, Steven M.; Aberle, Denise R.; Agopian, Vatche; Han, Steven-Huy B.; Ni, Xiaohui; Li, Wenyuan; Zhou, Xianghong Jasmine

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study Durvalumab加或不加Tremelimumab联合化疗作为转移性非小细胞肺癌一线治疗的简要报告: POSEIDON 3期研究中肿瘤PD-L1表达的结果

CLINICAL LUNG CANCER

IF3.3

2024-05-01

OAAI

Garon, Edward B.; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Trukhin, Dmytro; Kim, Sang -We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Kohlmann, Milena; Lowery, Caitlin; Mann, Helen; Peters, Solange; Mok, Tony S.; Johnson, Melissa L.

MK-2870-004: A phase 3 study of MK-2870 (SKB264) versus chemotherapy for previously treated advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) with EGFR mutations or other genomic alterations

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Cappuzzo, Federico; Garon, Edward B.; Ahn, Myung-Ju; Lu, Shun; Kato, Terufumi; Felip, Enriqueta; Cheema, Parneet; Girard, Nicolas; Shamoun, Mark; Wang, Guoqing; Zhao, Bin; Hui, Rina

Phase I trial of intratumoral administration of autologous CCL21 gene-modified dendritic cells in combination with pembrolizumab for advanced NSCLC: Feasibility of repeated IT injections

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Liu, Bin; Lisberg, Aaron; Salehi-Rad, Ramin; Oh, Michael; Lee, Jay M.; Tran, Linh M.; Krysan, Kostyantyn; Lim, Raymond J.; Dumitras, Camelia; Jing, Zhe; Abtin, Fereidoun; Suh, Robert D.; Genshaft, Scott J.; Oh, Scott S.; Fishbein, Gregory A.; Kaul, Anita; Kahlon, Kanwarpal S.; Ashouri, Shahryar A.; Goldman, Jonathan W.; Elashoff, David A.; Garon, Edward; Dubinett, Steven M.

Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132)

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Izar, Benjamin; Zamarin, Dmitriy; Spigel, David R.; Hoimes, Christopher J.; McDermott, David F.; Sehgal, Kartik; Najjar, Yana G.; Schoenfeld, Adam J.; Garon, Edward B.; Sullivan, Ryan J.; Henick, Brian S.; Leal, Ticiana A.; Hurwitz, Michael E.; McKay, Rana R.; Busby, Natalie; Mehta-Damani, Anita; Azrilevich, Alex; Tran, Tony; Rizvi, Naiyer; Oft, Martin; Spira, Alexander I.

FURVENT, Phase 3 trial testing furmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertions (FURMO-004)

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Spira, Alexander; Cho, Byoung Chul; Felip, Enriqueta; Garon, Edward; Goto, Koichi; Johnson, Melissa Lynne; Leighl, Natasha B.; Passaro, Antonio; Planchard, David; Popat, Sanjay; Yang, James; Lu, Xiaoqian; Jiang, Yong; Huang, Jack; Lam, Morgan; Kowanetz, Marcin; Wang, Shirley; Le, John; Hsu, Jerry; Zhou, Caicun

Spatially resolved human leukocyte antigen (HLA) expression correlates with motif neoepitope expression and durable response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC)

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Goldman, Lucas; Gorbatov, Sarah; Shen, Collin; Berezowitz, Alexa; Garon, Edward; Cummings, Amy Lauren

Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-03-01

OAAI

Brahmer, Julie R.; Long, Georgina, V; Hamid, Omid; Garon, Edward B.; Herbst, Roy S.; Andre, Thierry; Armand, Philippe; Bajorin, Dean; Bellmunt, Joaquim; Burtness, Barbara; Choueiri, Toni K.; Cohen, Ezra E. W.; Diaz Jr, Luis A.; Shitara, Kohei; Kulkarni, Girish; McDermott, David; Shah, Manish; Tabernero, Josep; Vogel, Arndt; Zinzani, Pier Luigi; Jafari, Niusha; Birdu, Steven; Snyderu, Ellen; Gause, Christine; Braccou, Oswaldo L.; Pietanza, M. Catherine; Gruberu, Todd; Ribas, Antoni

研究方向